Angiotensin Converting Enzyme (ACE)

Clinical Chemistry


Description

Higher serum activity has been observed in children and young adults ( Buhlmann kit insert ). Increased ACE activity is found in sarcoidosis and a variety of chronic inflammatory pulmonary diseases, rheumatoid arthritis, connective tissue disease, Gaucher's disease and untreated hyperthyroidism. Decreased levels are seen in the use of ACE inhibitors and in haemolysed or lipaemic samples.


Indications

Monitoring of sarcoidosis and other inflammatory conditions with increased ACE.


Sample Type

Serum, SST/Gel, minimum 2ml ( 1ml separated serum ), Not EDTA sample. CSF by arrangement ( plain tube, not fluoride-oxalate )


Reference Range

Reference ranges are provided on the report. Alternatively, please contact the laboratory for current ranges.


Turnaround Time

Within 3 days


Testing Frequency

As required


External Notes

CSF ACE is not measured in the RHH laboratory. If required, please contact duty biochemist (via STH Switch) to arrange. Turnaround time for CSF ACE may be several weeks.

Long-term storage of serum samples - 6 months at -20C. (Source: Buhlmann)


Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

You are enquiring about

Angiotensin Converting Enzyme (ACE)